Sleep and Metabolism
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-40
SponsorOregon Health and Science University
About this trial
The goal of this study is to uncover sleep and circadian mechanisms contributing to adverse metabolic health. The protocol is a 21 day (7 outpatient days, 14 inpatient days) mechanistic randomized-crossover study designed to identify the impact of chronic sleep restriction and circadian timing, independently and in combination on energy metabolism and identify the independent and combined effects on glucose tolerance.
Eligibility criteria
Qualifiers
Between 18 and 40 years of age
Drug free
Established disease-free status
Disqualifiers
Dietary restrictions
Participants who choose not to or cannot consume dairy products (milk, yogurt, cheese, ice cream)
Body Composition
Psychiatric/psychological suitability
Trial design
Treatments tested in this trial
- Sleep Restriction
Treatment groups
20 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov